Cases 31 - 40 of 58
CASE NUMBER NOT USED
as 1:2020cv01371
Defendant:
LEK PHARMACEUTICALS D.D., MACLEODS PHARMA USA, INC., APOTEX INC. and others
Plaintiff:
TAKEDA PHARMACEUTICALS INTERNATIONAL AG, H. LUNDBECK A/S, TAKEDA PHARMACEUTICALS U.S.A., INC. (TPUSA) and others
Interested Party:
ANITA H CLAYTON
ACTELION PHARMACEUTICALS LTD et al v. MSN PHARMACEUTICALS INC. et al
as 1:2020cv03859
Defendant:
ZYDUS WORLDWIDE DMCC, MSN LABORATORIES PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED and others
Plaintiff:
NIPPON SHINYAKU CO., LTD. and ACTELION PHARMACEUTICALS LTD
Cause Of Action: 15 U.S.C. § 1126
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB et al v. Alembic Pharmaceuticals Limited et al
as 1:2020cv00202
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Cadilla Healthcare Ltd. and others
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 1
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2020cv00074
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and Alembic Pharmaceuticals Limited
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2019cv02021
Defendant:
Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Alembic Global Holding SA and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2019cv02007
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2019cv01885
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA et al
as 1:2019cv00956
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals, Ltd. and Alembic Pharmaceuticals, Inc.
Plaintiff:
CyDex Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
